In a KRAS-mutated murine PDAC cell model, tumor-intrinsic CXCL1 expression alone determines the quantitative and qualitative features of infiltrative CD8+ T cells and hence response to checkpoint immunotherapy [41]. Here, KRAS is linked to neoplasm.